When taking COVID, a person should be aware of a variety of potential health risks. It is possible, for instance, that it will cause problems with the heart or even infertility. There is also the possibility of developing lung complications. Depression and delirium are two of the additional problems that can occur.
A recent study reveals that patients with COVID-19 have an increased risk of heart problems, even if their condition is not already considered severe. The findings were presented in a paper that was published in JAMA Cardiology.
The health of 153,760 COVID patients was investigated by the researchers. They discovered that those individuals who had a positive COVID test had a rate of serious cardiac events that was 4% higher than average over the course of the subsequent twelve months.
Even though it is believed that the COVID-19 virus has avoided the virus's most severe side effects, the inflammation that results from the infection can still lead to the development of myocarditis. Myocarditis is an inflammation of the muscle cells that causes an increase in the amount of work that the heart has to do. It has been linked to scar tissue formation and abnormal heart rhythms.
After receiving treatment for COVID, respiratory fibrosis and ARDS are two of the most serious lung complications that can occur. This is due to the fact that COVID-19 causes an immune response, which then has the potential to affect a variety of organs throughout the body. COVID-19 can cause a variety of symptoms, including but not limited to shortness of breath, coughing, and fever. COVID-19 has also been linked to pulmonary vascular disease.
Recent research and publications have brought to light the possibility that antifibrotic drugs could be beneficial in treating fibrosing lung diseases. The use of antifibrotic drugs is safe and may be beneficial in COVID-19. These drugs are well tolerated. However, additional research is required to develop a better understanding of the role that fibrosis plays in COVID-19.
A number of studies have demonstrated that the COVID-19 virus can have an effect on male fertility. However, there is a paucity of evidence regarding the effect that the disease has on the fertility of females.
Infection with a COVID can have a negative impact on the quality of sperm and the function of oocytes. According to a number of studies, infections of moderate to severe severity can lead to inflammation of the testicles and a lower sperm count.